Parsec Financial Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $1.91M | Buy |
17,978
+474
| +3% | +$51.2K | 0.08% | 133 |
|
|
2022
Q4 | $1.94M | Buy |
17,504
+4,563
| +35% | +$466K | 0.09% | 136 |
|
|
2022
Q3 | $1.11M | Sell |
12,941
-2,908
| -18% | -$260K | 0.06% | 157 |
|
|
2022
Q2 | $1.45M | Buy |
15,849
+3,159
| +25% | +$280K | 0.07% | 147 |
|
|
2022
Q1 | $1.04M | Buy |
12,690
+291
| +2% | +$22.9K | 0.04% | 170 |
|
|
2021
Q4 | $950K | Hold |
12,399
| – | – | 0.04% | 164 |
|
|
2021
Q3 | $1.03M | Sell |
12,399
-710
| -5% | -$54K | 0.04% | 159 |
|
|
2021
Q2 | $1.02M | Sell |
13,109
-583
| -4% | -$43.4K | 0.05% | 147 |
|
|
2021
Q1 | $1.01M | Buy |
13,692
+621
| +5% | +$45.8K | 0.05% | 142 |
|
|
2020
Q4 | $1.02M | Sell |
13,071
-124
| -0.9% | -$9.48K | 0.06% | 136 |
|
|
2020
Q3 | $1.04M | Buy |
13,195
+87
| +0.7% | +$6.82K | 0.06% | 132 |
|
|
2020
Q2 | $967K | Sell |
13,108
-2,332
| -15% | -$176K | 0.06% | 135 |
|
|
2020
Q1 | $1.13M | Buy |
15,440
+475
| +3% | +$37.3K | 0.09% | 124 |
|
|
2019
Q4 | $1.3M | Sell |
14,965
-670
| -4% | -$55K | 0.08% | 126 |
|
|
2019
Q3 | $1.26M | Sell |
15,635
-1,048
| -6% | -$84K | 0.08% | 123 |
|
|
2019
Q2 | $1.33M | Buy |
16,683
+3,404
| +26% | +$261K | 0.08% | 128 |
|
|
2019
Q1 | $1.05M | Sell |
13,279
-3,209
| -19% | -$240K | 0.07% | 138 |
|
|
2018
Q4 | $1.2M | Buy |
16,488
+1,260
| +8% | +$88.9K | 0.09% | 134 |
|
|
2018
Q3 | $1.03M | Buy |
15,228
+434
| +3% | +$27.6K | 0.07% | 140 |
|
|
2018
Q2 | $857K | Buy |
14,794
+4,000
| +37% | +$226K | 0.06% | 147 |
|
|
2018
Q1 | $561K | Buy |
10,794
+190
| +2% | +$10.3K | 0.04% | 168 |
|
|
2017
Q4 | $569K | Sell |
10,604
-1,447
| -12% | -$80.2K | 0.04% | 174 |
|
|
2017
Q3 | $736K | Hold |
12,051
| – | – | 0.05% | 167 |
|
|
2017
Q2 | $737K | Buy |
12,051
+427
| +4% | +$26K | 0.06% | 138 |
|
|
2017
Q1 | $705K | Sell |
11,624
-2,974
| -20% | -$180K | 0.06% | 135 |
|
|
2016
Q4 | $820K | Sell |
14,598
-35
| -0.2% | -$2.05K | 0.07% | 131 |
|
|
2016
Q3 | $871K | Buy |
14,633
+1,636
| +13% | +$95.7K | 0.08% | 132 |
|
|
2016
Q2 | $714K | Buy |
12,997
+613
| +5% | +$32.6K | 0.07% | 130 |
|
|
2016
Q1 | $625K | Sell |
12,384
-1,740
| -12% | -$85.2K | 0.06% | 127 |
|
|
2015
Q4 | $712K | Buy |
14,124
+1,461
| +12% | +$73.7K | 0.07% | 124 |
|
|
2015
Q3 | $597K | Buy |
12,663
+1,654
| +15% | +$87.9K | 0.07% | 128 |
|
|
2015
Q2 | $598K | Buy |
11,009
+29
| +0.3% | +$1.63K | 0.06% | 127 |
|
|
2015
Q1 | $602K | Sell |
10,980
-946
| -8% | -$53.6K | 0.06% | 128 |
|
|
2014
Q4 | $646K | Buy |
11,926
+1,778
| +18% | +$99.1K | 0.07% | 117 |
|
|
2014
Q3 | $574K | Hold |
10,148
| – | – | 0.06% | 114 |
|
|
2014
Q2 | $560K | Buy |
10,148
+943
| +10% | +$51.4K | 0.06% | 113 |
|
|
2014
Q1 | $499K | Sell |
9,205
-3,039
| -25% | -$157K | 0.06% | 110 |
|
|
2013
Q4 | $585K | Buy |
12,244
+4,304
| +54% | +$197K | 0.07% | 104 |
|
|
2013
Q3 | $361K | Buy |
7,940
+541
| +7% | +$24.7K | 0.05% | 108 |
|
|
2013
Q2 | $328K | Buy |
+7,399
| New | +$330K | 0.04% | 111 |
|
Other funds holding MRK
Parsec Financial Management's MRK Position: Q1 2023 in Review
Parsec Financial Management increased its Merck (MRK) stake by 2.7% in Q1 2023, buying an estimated $51.2K and bringing the position to 17,978 shares worth $1.91M. The position accounts for 0.08% of the portfolio, ranked #133.
Parsec Financial Management first reported a position in MRK in Q2 2013 and has held it in 40 quarters since. The position peaked at $1.94M in Q4 2022. 3,179 funds tracked by Wall St. Rank hold MRK as of Q1 2023.
- Parsec Financial Management held 17,978 shares of Merck worth $1.91M as of Q1 2023.
- Parsec Financial Management bought 474 Merck shares in Q1 2023, an estimated $51.2K.
- Merck made up 0.08% of Parsec Financial Management's portfolio in Q1 2023, its #133 holding.
- Parsec Financial Management first reported a position in Merck in Q2 2013 and has held it in 40 quarters since.
- Parsec Financial Management's Merck position peaked at $1.94M in Q4 2022.
- 3,179 funds tracked by Wall St. Rank held Merck as of Q1 2023.
Based on Parsec Financial Management's 13F filing for Q1 2023, filed 6 Apr 2023.